Virginie Sauvage
Pasteur Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Virginie Sauvage.
PLOS ONE | 2012
Vincent Foulongne; Virginie Sauvage; Charles Hébert; Justine Cheval; Meriadeg Ar Gouilh; Kevin Pariente; Michel Segondy; Ana Maria Burguière; Jean-Claude Manuguerra; Valérie Caro; Marc Eloit
The human skin is a complex ecosystem that hosts a heterogeneous flora. Until recently, the diversity of the cutaneous microbiota was mainly investigated for bacteria through culture based assays subsequently confirmed by molecular techniques. There are now many evidences that viruses represent a significant part of the cutaneous flora as demonstrated by the asymptomatic carriage of beta and gamma-human papillomaviruses on the healthy skin. Furthermore, it has been recently suggested that some representatives of the Polyomavirus genus might share a similar feature. In the present study, the cutaneous virome of the surface of the normal-appearing skin from five healthy individuals and one patient with Merkel cell carcinoma was investigated through a high throughput metagenomic sequencing approach in an attempt to provide a thorough description of the cutaneous flora, with a particular focus on its viral component. The results emphasize the high diversity of the viral cutaneous flora with multiple polyomaviruses, papillomaviruses and circoviruses being detected on normal-appearing skin. Moreover, this approach resulted in the identification of new Papillomavirus and Circovirus genomes and confirmed a very low level of genetic diversity within human polyomavirus species. Although viruses are generally considered as pathogen agents, our findings support the existence of a complex viral flora present at the surface of healthy-appearing human skin in various individuals. The dynamics and anatomical variations of this skin virome and its variations according to pathological conditions remain to be further studied. The potential involvement of these viruses, alone or in combination, in skin proliferative disorders and oncogenesis is another crucial issue to be elucidated.
Journal of Clinical Microbiology | 2011
Justine Cheval; Virginie Sauvage; Lionel Frangeul; Laurent Dacheux; Ghislaine Guigon; Nicolas Dumey; Kevin Pariente; Claudine Rousseaux; Fabien Dorange; Nicolas Berthet; Sylvain Brisse; Ivan Moszer; Hervé Bourhy; Claude Jean Manuguerra; Marc Lecuit; Ana Maria Burguière; Valérie Caro; Marc Eloit
ABSTRACT High-throughput sequencing furnishes a large number of short sequence reads from uncloned DNA and has rapidly become a major tool for identifying viruses in biological samples, and in particular when the target sequence is undefined. In this study, we assessed the analytical sensitivity of a pipeline for detection of viruses in biological samples based on either the Roche-454 genome sequencer or Illumina genome analyzer platforms. We sequenced biological samples artificially spiked with a wide range of viruses with genomes composed of single or double-stranded DNA or RNA, including linear or circular single-stranded DNA. Viruses were added at a very low concentration most often corresponding to 3 or 0.8 times the validated level of detection of quantitative reverse transcriptase PCRs (RT-PCRs). For the viruses represented, or resembling those represented, in public nucleotide sequence databases, we show that the higher output of Illumina is associated with a much greater sensitivity, approaching that of optimized quantitative (RT-)PCRs. In this blind study, identification of viruses was achieved without incorrect identification. Nevertheless, at these low concentrations, the number of reads generated by the Illumina platform was too small to facilitate assembly of contigs without the use of a reference sequence, thus precluding detection of unknown viruses. When the virus load was sufficiently high, de novo assembly permitted the generation of long contigs corresponding to nearly full-length genomes and thus should facilitate the identification of novel viruses.
Journal of Virology | 2011
Virginie Sauvage; Justine Cheval; Vincent Foulongne; Meriadeg Ar Gouilh; Kevin Pariente; Jean Claude Manuguerra; Jennifer Richardson; Olivier Dereure; Marc Lecuit; Ana Maria Burguière; Valérie Caro; Marc Eloit
ABSTRACT We have identified in a skin swab sample from a healthy donor a new virus that we have named human gyrovirus (HGyV) because of its similarity to the chicken anemia virus (CAV), the only previously known member of the Gyrovirus genus. In particular, this virus encodes a homolog of the CAV apoptin, a protein that selectively induces apoptosis in cancer cells. By PCR screening, HGyV was found in 5 of 115 other nonlesional skin specimens but in 0 of 92 bronchoalveolar lavages or nasopharyngeal aspirates and in 0 of 92 fecal samples.
Emerging Infectious Diseases | 2011
Virginie Sauvage; Vincent Foulongne; Justine Cheval; Meriadeg Ar Gouilh; Kevin Pariente; Olivier Dereure; Jean-Claude Manuguerra; Jennifer Richardson; Marc Lecuit; Ana Maria Burguiere; Valérie Caro; Marc Eloit
TOC summary: This virus is shed at the human skin surface.
Journal of Virology | 2012
Virginie Sauvage; Meriadeg Ar Gouilh; Justine Cheval; Erika Muth; Kevin Pariente; Ana Maria Burguiere; Valérie Caro; Jean-Claude Manuguerra; Marc Eloit
ABSTRACT During a study of the fecal microbiomes from two healthy piglets using high-throughput sequencing (HTS), we identified a viral genome containing an open reading frame encoding a predicted polyprotein of 2,133 amino acids. This novel viral genome displayed the typical organization of picornaviruses, containing three structural proteins (VP0, VP3, and VP1), followed by seven nonstructural proteins (2A, 2B, 2C, 3A, 3B, 3Cpro, and 3Dpol). Given its particular relationship with Parechovirus, we propose to name it “Pasivirus” for Parecho sister clade virus, with “Swine pasivirus 1” (SPaV1) as the type species. Fecal samples collected at an industrial farm from healthy sows and piglets from the same herd (25 and 75, respectively) with ages ranging from 4 to 28 weeks were analyzed for the presence of SPaV1 by one-step reverse transcription (RT)-PCR targeting a 3D region of 151 bp. SPaV1 was detected in fecal samples from 51/75 healthy piglets (68% of the animals) and in none of the 25 fecal samples from healthy sows, indicating that SPaV1 circulates through enteric infection of healthy piglets. We propose that SPaV1 represents the first member of a novel Picornaviridae genus related to parechoviruses.
Clinical Microbiology and Infection | 2014
C. Bodemer; Virginie Sauvage; Nizar Mahlaoui; Justine Cheval; Thérèse Couderc; S. Leclerc-Mercier; Marianne Debré; Isabelle Pellier; Léa Gagnieur; Sylvie Fraitag; Alain Fischer; Stéphane Blanche; Marc Lecuit; Marc Eloit
Granulomas may develop as a response to a local antigenic trigger, leading to the activation of macrophages and T-lymphocytes. Primary immunodeficiency (PID) is associated with the development of extensive cutaneous granulomas, whose aetiology remains unknown. We performed high-throughput sequencing of the transcriptome of cutaneous granuloma lesions on two consecutive index cases, and RT-PCR in a third consecutive patient. The RA27/3 vaccine strain of rubella virus-the core component of a universally used paediatric vaccine-was present in the cutaneous granuloma of these three consecutive PID patients. Controls included the healthy skin of two patients, non-granulomatous cutaneous lesions of patients with immunodeficiency, and skin biopsy samples of healthy individuals, and were negative. Expression of viral antigens was confirmed by immunofluorescence. Persistence of the rubella vaccine virus was also demonstrated in granuloma lesions sampled 4-5 years earlier. The persistence of the rubella virus vaccine strain in all three consecutive cutaneous granuloma patients with PID strongly suggests a causal relationship between rubella virus and granuloma in this setting.
Journal of Investigative Dermatology | 2013
O. Dereure; Justine Cheval; Aurélie Du Thanh; Kevin Pariente; Virginie Sauvage; Jean Claude Manuguerra; Valérie Caro; Vincent Foulongne; Marc Eloit
(Supplementary Table S2 online), we calculate that the total concentration of these three keratins in the average nonstem basal keratinocyte is B40mgml 1 or 520mM (Supplementary Table S3 online). By comparison, the total actin concentration ranges between 25 and 200mM in various cell types (Pollard et al., 2000), and is reportedly up to 900mM in skeletal muscle cells (Jaeger et al., 2009). The latter figures convey that the concentration of keratin in basal keratinocytes approximates that of actin in muscle tissue. Further, our assumptions and measurements together yield a total protein concentration of B180mgml 1 in sorted keratinocytes (Supplementary Table S3 online), a figure that is consistent with previous reported values for mammalian cells (50–400mgml ; Schnell and Turner, 2004). We note that although the soluble pool represents only 2% of the total keratin proteins in basal keratinocytes (Bernot et al., 2005), the corresponding number of protein monomers (B1.9 million, Figure 2e) and concentration (B10mM, Supplementary Table S3 online) is large, relative to the pool of most other cellular proteins. This sizable soluble pool is presumably available to sustain the remodeling of keratin filaments under steady-state conditions, and/or to fulfill nonstructural roles in the cell. These quantitative figures are essential to a deeper understanding of keratin organization and function, and their regulation, in epidermis and related surface epithelia.
PLOS ONE | 2018
Virginie Sauvage; Laure Boizeau; Daniel Candotti; Mathias Vandenbogaert; Annabelle Servant-Delmas; Valérie Caro; Syria Laperche
Until recently, the method of choice to characterize viral diversity consisted in cloning PCR amplicons of full-length viral genomes and Sanger-sequencing of multiple clones. However, this is extremely laborious, time-consuming, and low-throughput. Next generation short-read sequencing appears also limited by its inability to directly sequence full-length viral genomes. The MinION™ device recently developed by Oxford Nanopore Technologies can be a promising alternative by applying long-read single-molecule sequencing directly to the overall amplified products generated in a PCR reaction. This new technology was evaluated by using hepatitis B virus (HBV) as a model. Several previously characterized HBV-infected clinical samples were investigated including recombinant virus, variants that harbored deletions and mixed population. Original MinION device was able to generate individual complete 3,200-nt HBV genome sequences and to identify recombinant variants. MinION was particularly efficient in detecting HBV genomes with multiple large in-frame deletions and spliced variants concomitantly with non-deleted parental genomes. However, an average-12% sequencing error rate per individual reads associated to a low throughput challenged single-nucleotide resolution, polymorphism calling and phasing mutations directly from the sequencing reads. Despite this high error rate, the pairwise identity of MinION HBV consensus genome was consistent with Sanger sequencing method. MinION being under continuous development, further studies are needed to evaluate its potential use for viral infection characterization.
Infection, Genetics and Evolution | 2018
Virginie Sauvage; Johanna Gomez; Anaïs Barray; Mathias Vandenbogaert; Laure Boizeau; Claude Tayou Tagny; Olivat Rakoto; Pascal Bizimana; Hassana Guitteye; Ba Bocar Ciré; Hadiza Soumana; Jean-Baptiste Shuli Tchomba; Valérie Caro; Syria Laperche
Cycloviruses, small ssDNA viruses belonging to the Circoviridae family, have been suggested as possible causes of enteric, respiratory and neurological disorders in human patients. One of these species, cyclovirus-Vietnam (CyCV-VN), initially isolated from cerebrospinal fluid samples of patients with unexplained neurological disorders, has since been reported in serum samples from chronically patients infected with HBV, HCV or HIV, in Italy. On the other hand, CyCV-VN was not detected in serum samples from healthy individuals. Here, we report on a high prevalence of 43.4% (40/92) of CyCV-VN in plasma samples from asymptomatic blood donors from Madagascar. Interestingly, this virus was not detected by metagenomics and PCR in six other African countries, suggesting regional differences in CyCV-VN prevalence across Africa. Phylogenetic analysis based on the complete genomes showed that CyCV-VN sequences isolated from blood were most closely related to sequences previously reported from human stool in Madagascar. Further investigations using larger cohorts are required to determine the global epidemiology, the natural history and the pathological significance, if any, of CyCV-VN infection in humans.
Annals of Internal Medicine | 2018
Daniel Candotti; Xuelian Deng; Tingting Li; Syria Laperche; Virginie Sauvage